These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37358954)

  • 1. Distinct and shared neuropsychiatric phenotypes in FTLD-tauopathies.
    Keszycki R; Kawles A; Minogue G; Zouridakis A; Macomber A; Gill N; Vu M; Zhang H; Coventry C; Rogalski E; Weintraub S; Mesulam MM; Geula C; Gefen T
    Front Aging Neurosci; 2023; 15():1164581. PubMed ID: 37358954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological correlations in behavioural variant frontotemporal dementia.
    Perry DC; Brown JA; Possin KL; Datta S; Trujillo A; Radke A; Karydas A; Kornak J; Sias AC; Rabinovici GD; Gorno-Tempini ML; Boxer AL; De May M; Rankin KP; Sturm VE; Lee SE; Matthews BR; Kao AW; Vossel KA; Tartaglia MC; Miller ZA; Seo SW; Sidhu M; Gaus SE; Nana AL; Vargas JNS; Hwang JL; Ossenkoppele R; Brown AB; Huang EJ; Coppola G; Rosen HJ; Geschwind D; Trojanowski JQ; Grinberg LT; Kramer JH; Miller BL; Seeley WW
    Brain; 2017 Dec; 140(12):3329-3345. PubMed ID: 29053860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology.
    Giannini LAA; Peterson C; Ohm D; Xie SX; McMillan CT; Raskovsky K; Massimo L; Suh E; Van Deerlin VM; Wolk DA; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
    Acta Neuropathol Commun; 2021 Feb; 9(1):30. PubMed ID: 33622418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau).
    Gibbons GS; Kim SJ; Robinson JL; Changolkar L; Irwin DJ; Shaw LM; Lee VM; Trojanowski JQ
    Acta Neuropathol Commun; 2019 Mar; 7(1):34. PubMed ID: 30832741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study.
    Thijssen EH; La Joie R; Strom A; Fonseca C; Iaccarino L; Wolf A; Spina S; Allen IE; Cobigo Y; Heuer H; VandeVrede L; Proctor NK; Lago AL; Baker S; Sivasankaran R; Kieloch A; Kinhikar A; Yu L; Valentin MA; Jeromin A; Zetterberg H; Hansson O; Mattsson-Carlgren N; Graham D; Blennow K; Kramer JH; Grinberg LT; Seeley WW; Rosen H; Boeve BF; Miller BL; Teunissen CE; Rabinovici GD; Rojas JC; Dage JL; Boxer AL;
    Lancet Neurol; 2021 Sep; 20(9):739-752. PubMed ID: 34418401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter hyperintensities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer's disease.
    Desmarais P; Gao AF; Lanctôt K; Rogaeva E; Ramirez J; Herrmann N; Stuss DT; Black SE; Keith J; Masellis M
    Alzheimers Res Ther; 2021 Jul; 13(1):129. PubMed ID: 34256835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progressive nonfluent aphasia].
    Murayama S; Saito Y
    Brain Nerve; 2011 Oct; 63(10):1037-46. PubMed ID: 21987561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracortical diffusion tensor imaging signature of microstructural changes in frontotemporal lobar degeneration.
    Torso M; Ridgway GR; Jenkinson M; Chance S;
    Alzheimers Res Ther; 2021 Oct; 13(1):180. PubMed ID: 34686217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining Neuropsychiatric Inventory scale differences across frontotemporal dementia syndromes.
    Yiannopoulou KG; Papatriantafyllou JD; Ghika A; Tsinia N; Lykou E; Hatziantoniou E; Agiomyrgiannakis D; Kyrozis A; Papageorgiou SG
    Psychogeriatrics; 2019 Jan; 19(1):32-37. PubMed ID: 30073726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement and characterization of distinctive clinical phenotypes using the Frontotemporal Lobar Degeneration Module (FTLD-MOD).
    Gefen T; Teylan MA; Besser L; Pollner E; Moshkovich A; Weintraub S
    Alzheimers Dement; 2020 Jun; 16(6):918-925. PubMed ID: 32400973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases?
    Sha S; Hou C; Viskontas IV; Miller BL
    Nat Clin Pract Neurol; 2006 Dec; 2(12):658-65. PubMed ID: 17117169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.
    Josephs KA; Petersen RC; Knopman DS; Boeve BF; Whitwell JL; Duffy JR; Parisi JE; Dickson DW
    Neurology; 2006 Jan; 66(1):41-8. PubMed ID: 16401843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of Syndromes Associated With Frontotemporal Lobar Degeneration in 9 European Countries.
    Logroscino G; Piccininni M; Graff C; Hardiman O; Ludolph AC; Moreno F; Otto M; Remes AM; Rowe JB; Seelaar H; Solje E; Stefanova E; Traykov L; Jelic V; Rydell MT; Pender N; Anderl-Straub S; Barandiaran M; Gabilondo A; Krüger J; Murley AG; Rittman T; van der Ende EL; van Swieten JC; Hartikainen P; Stojmenovic GM; Mehrabian S; Benussi L; Alberici A; Dell'Abate MT; Zecca C; Borroni B;
    JAMA Neurol; 2023 Mar; 80(3):279-286. PubMed ID: 36716024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia.
    Mesulam MM; Weintraub S; Rogalski EJ; Wieneke C; Geula C; Bigio EH
    Brain; 2014 Apr; 137(Pt 4):1176-92. PubMed ID: 24574501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathomechanisms and clinical aspects of frontotemporal lobar degeneration].
    Bürger K; Arzberger T; Stephan J; Levin J; Edbauer D
    Nervenarzt; 2017 Feb; 88(2):163-172. PubMed ID: 27999880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct early symptoms in neuropathologically proven frontotemporal lobar degeneration.
    Kawakami I; Arai T; Shinagawa S; Niizato K; Oshima K; Ikeda M
    Int J Geriatr Psychiatry; 2021 Jan; 36(1):38-45. PubMed ID: 32748432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychiatric symptom profile differs based on pathology in patients with clinically diagnosed behavioral variant frontotemporal dementia.
    Léger GC; Banks SJ
    Dement Geriatr Cogn Disord; 2014; 37(1-2):104-12. PubMed ID: 24135712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Looking for Measures of Disease Severity in the Frontotemporal Dementia Continuum.
    Premi E; Gualeni V; Costa P; Cosseddu M; Gasparotti R; Padovani A; Borroni B
    J Alzheimers Dis; 2016 Apr; 52(4):1227-35. PubMed ID: 27104906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral variant of frontotemporal dementia: Fundamental clinical issues associated with prediction of pathological bases.
    Miki T; Yokota O; Ishizu H; Kuroda S; Oshima E; Terada S; Yamada N
    Neuropathology; 2016 Aug; 36(4):388-404. PubMed ID: 26969837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential vulnerability of the dentate gyrus to tauopathies in dementias.
    Kawles A; Minogue G; Zouridakis A; Keszycki R; Gill N; Nassif C; Coventry C; Zhang H; Rogalski E; Flanagan ME; Castellani R; Bigio EH; Mesulam MM; Geula C; Gefen T
    Acta Neuropathol Commun; 2023 Jan; 11(1):1. PubMed ID: 36597124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.